Literature DB >> 2475360

Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.

S Tanikawa1, I Nakao, K Tsuneoka, N Nara.   

Abstract

We have attempted to evaluate in vivo effects of granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on acute radiation hematopoietic injury in mice. BDF1 mice, irradiated with 7.5-Gy x-rays, were injected i.p. twice daily for 10 days with 10(5) U recombinant human G-CSF, 3.75 x 10(5) U recombinant murine GM-CSF, or a combination of both. G-CSF significantly enhanced the recovery of not only peripheral leukocytes but also platelets and hematocrit on days 14 and 21 after irradiation. GM-CSF significantly enhanced the recovery of platelets on day 14 and peripheral leukocytes on day 21. G-CSF markedly enhanced the recovery of spleen colony-forming units (CFU-S), colony-forming units in culture (CFU-C), erythroid burst-forming units (BFU-E), and megakaryocyte colony-forming units (CFU-Meg) both in bone marrow and in the spleen. GM-CSF significantly enhanced the recovery of CFU-Meg in bone marrow on day 14. We found synergistic effects between G-CSF and GM-CSF on CFU-S, CFU-C, and CFU-Meg in the spleen on day 14, although we found antagonistic effects between G-CSF and GM-CSF on CFU-S and CFU-C in bone marrow on day 7, and on platelet counts on day 7. These results indicate that the administration of recombinant G-CSF and GM-CSF may be useful in accelerating hematopoietic recovery in patients with acute radiation hematopoietic injuries.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475360

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Different effect of granulocyte colony-stimulating factor or bacterial infection on bone-marrow cells of cyclophosphamide-treated or irradiated mice.

Authors:  A M Buisman; T L Van Zwet; J A Langermans; M F Geertsma; P J Leenen; R van Furth
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

2.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

3.  Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation.

Authors:  K Nomoto; T Yokokura; M Mitsuyama; Y Yoshikai; K Nomoto
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 4.  Radiation countermeasure agents: an update (2011-2014).

Authors:  Vijay K Singh; Victoria L Newman; Patricia L P Romaine; Stephen Y Wise; Thomas M Seed
Journal:  Expert Opin Ther Pat       Date:  2014-10-14       Impact factor: 6.674

5.  A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancer.

Authors:  S Kehoe; C J Poole; A Stanley; H M Earl; G R Blackledge
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

6.  G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses.

Authors:  Mark P Rubinstein; Mohamed L Salem; Andrew L Doedens; Caitlin J Moore; Cody Chiuzan; Guillermo L Rivell; David J Cole; Ananda W Goldrath
Journal:  J Hematol Oncol       Date:  2013-10-01       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.